Citadel Advisors’s Spindletop Health Acquisition Corp. Warrant SHCAW Stock Holding History

Citadel Advisors’s Portfolio SHCAW Stock Details SHCAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-47,809	Closed	-$4K	–	15813
2022 Q3	$4K	Buy	47,809 +17,519	+58%	+$1.93K	﹤0.01%	12400
2022 Q2	$3K	Sell	30,290 -344,710	-92%	-$53.1K	﹤0.01%	12717
2022 Q1	$53K	Hold	375,000	–	–	﹤0.01%	12758
2021 Q4	$188K	Buy	+375,000	New	+$206K	﹤0.01%	11945

Citadel Advisors's SHCAW Position: Q4 2022 in Review

Citadel Advisors sold out of Spindletop Health Acquisition Corp. Warrant (SHCAW) in Q4 2022, closing a stake of 47,809 shares — an estimated $4K sold.

Citadel Advisors first reported a position in SHCAW in Q4 2021 and held it in 4 quarters. The position peaked at $188K in Q4 2021. 0 funds tracked by Wall St. Rank hold SHCAW as of Q4 2022.

Citadel Advisors reported no remaining Spindletop Health Acquisition Corp. Warrant position as of Q4 2022 after selling out during the quarter.
Citadel Advisors sold 47,809 Spindletop Health Acquisition Corp. Warrant shares in Q4 2022, an estimated $4K.
Citadel Advisors first reported a position in Spindletop Health Acquisition Corp. Warrant in Q4 2021 and held it in 4 quarters.
Citadel Advisors's Spindletop Health Acquisition Corp. Warrant position peaked at $188K in Q4 2021.
0 funds tracked by Wall St. Rank held Spindletop Health Acquisition Corp. Warrant as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.